• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环神经血管导向分子及其与系统性硬化症外周微血管损伤的关系

Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis.

作者信息

Romano Eloisa, Rosa Irene, Fioretto Bianca Saveria, Matucci-Cerinic Marco, Manetti Mirko

机构信息

Division of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

Section of Anatomy and Histology, Department of Experimental and Clinical Medicine, University of Florence, 50134 Florence, Italy.

出版信息

Life (Basel). 2022 Jul 14;12(7):1056. doi: 10.3390/life12071056.

DOI:10.3390/life12071056
PMID:35888144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9316343/
Abstract

Systemic sclerosis (SSc, scleroderma) is a complex connective tissue disease whose earliest clinical manifestations are microvascular tone dysregulation and peripheral microcirculatory abnormalities. Following previous evidence of an association between circulating neurovascular guidance molecules and SSc disturbed angiogenesis, here, we measured the levels of soluble neuropilin 1 (sNRP1), semaphorin 3E (Sema3E), and Slit2 by enzyme-linked immunosorbent assay in serum samples from a large case series of 166 SSc patients vs. 110 healthy controls. We focused on their possible correlation with vascular disease clinical features and applied logistic regression analysis to determine which of them could better reflect disease activity and severity. Our results demonstrate that, in SSc: (i) sNRP1 is significantly decreased, with lower sNRP1 serum levels correlating with the severity of nailfold videocapillaroscopy (NVC) abnormalities and the presence of ischemic digital ulcers (DUs); (ii) both Sema3E and Slit2 are increased, with Sema3E better reflecting early NVC abnormalities; and (iii) higher Sema3E correlates with the absence of DUs, while augmented Slit2 associates with the presence of DUs. Receiver operator characteristics curve analysis revealed that both circulating sNRP1 and Sema3E show a moderate diagnostic accuracy. Moreover, logistic regression analysis allowed to identify sNRP1 and Sema3E as more suitable independent biomarkers reflecting the activity and severity of SSc-related peripheral microvasculopathy.

摘要

系统性硬化症(SSc,硬皮病)是一种复杂的结缔组织疾病,其最早的临床表现是微血管张力失调和外周微循环异常。此前有证据表明循环神经血管导向分子与SSc血管生成紊乱有关,在此,我们通过酶联免疫吸附测定法测量了166例SSc患者与110例健康对照者的大样本血清中可溶性神经纤毛蛋白1(sNRP1)、3E类信号素(Sema3E)和Slit2的水平。我们关注它们与血管疾病临床特征之间的可能相关性,并应用逻辑回归分析来确定它们中哪一个能更好地反映疾病活动度和严重程度。我们的结果表明,在SSc中:(i)sNRP1显著降低,较低的sNRP1血清水平与甲襞视频毛细血管镜检查(NVC)异常的严重程度以及缺血性指端溃疡(DU)的存在相关;(ii)Sema3E和Slit2均升高,Sema3E能更好地反映早期NVC异常;(iii)较高的Sema3E与无DU相关,而升高的Slit2与DU的存在相关。受试者工作特征曲线分析显示,循环sNRP1和Sema3E均具有中等诊断准确性。此外,逻辑回归分析确定sNRP1和Sema3E是更合适的独立生物标志物,可反映SSc相关外周微血管病变的活动度和严重程度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/282e785907eb/life-12-01056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/35710b12bba3/life-12-01056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/6938c36a38f1/life-12-01056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/c0aeded981c7/life-12-01056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/282e785907eb/life-12-01056-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/35710b12bba3/life-12-01056-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/6938c36a38f1/life-12-01056-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/c0aeded981c7/life-12-01056-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7236/9316343/282e785907eb/life-12-01056-g004.jpg

相似文献

1
Circulating Neurovascular Guidance Molecules and Their Relationship with Peripheral Microvascular Impairment in Systemic Sclerosis.循环神经血管导向分子及其与系统性硬化症外周微血管损伤的关系
Life (Basel). 2022 Jul 14;12(7):1056. doi: 10.3390/life12071056.
2
Plexin-D1/Semaphorin 3E pathway may contribute to dysregulation of vascular tone control and defective angiogenesis in systemic sclerosis.丛状蛋白-D1/信号素3E通路可能导致系统性硬化症中血管张力控制失调和血管生成缺陷。
Arthritis Res Ther. 2015 Aug 21;17(1):221. doi: 10.1186/s13075-015-0749-4.
3
Increased Circulating Soluble Junctional Adhesion Molecules in Systemic Sclerosis: Association with Peripheral Microvascular Impairment.系统性硬化症中循环可溶性连接黏附分子增加:与外周微血管损伤的关联
Life (Basel). 2022 Nov 4;12(11):1790. doi: 10.3390/life12111790.
4
Slit2/Robo4 axis may contribute to endothelial cell dysfunction and angiogenesis disturbance in systemic sclerosis.Slit2/Robo4 轴可能导致系统性硬化症中内皮细胞功能障碍和血管生成障碍。
Ann Rheum Dis. 2018 Nov;77(11):1665-1674. doi: 10.1136/annrheumdis-2018-213239. Epub 2018 Jul 18.
5
Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.神经纤毛蛋白-1 表达下调作为系统性硬化症外周微血管病和血管生成缺陷的新关键因素。
Ann Rheum Dis. 2016 Aug;75(8):1541-9. doi: 10.1136/annrheumdis-2015-207483. Epub 2015 Sep 10.
6
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis.系统性硬化症中,血清SIRT1和SIRT3水平降低与皮肤和肺部纤维化及外周微血管病变的严重程度相关。
J Clin Med. 2022 Mar 1;11(5):1362. doi: 10.3390/jcm11051362.
7
IL33 and sST2 serum level in systemic sclerosis microvascular involvement.白细胞介素 33 和可溶性 ST2 血清水平与系统性硬化症微血管受累。
Microvasc Res. 2022 Jul;142:104344. doi: 10.1016/j.mvr.2022.104344. Epub 2022 Feb 16.
8
Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.血管生成性T细胞扩增与系统性硬化症外周血管损伤的严重程度相关。
PLoS One. 2017 Aug 10;12(8):e0183102. doi: 10.1371/journal.pone.0183102. eCollection 2017.
9
In systemic sclerosis skin perfusion of hands is reduced and may predict the occurrence of new digital ulcers.在系统性硬化症中,手部皮肤灌注减少,且可能预示新的指端溃疡的发生。
Microvasc Res. 2017 Mar;110:1-4. doi: 10.1016/j.mvr.2016.11.003. Epub 2016 Nov 9.
10
Color Doppler Ultrasonography of digital arteries and digital ulcers development in systemic sclerosis.系统性硬化症患者的指动脉彩色多普勒超声与指溃疡的发生。
Microvasc Res. 2021 Nov;138:104210. doi: 10.1016/j.mvr.2021.104210. Epub 2021 Jun 16.

引用本文的文献

1
Cerebrovascular Involvement in Systemic Sclerosis.系统性硬化症中的脑血管受累
ACR Open Rheumatol. 2025 Apr;7(4):e70032. doi: 10.1002/acr2.70032.
2
Biomarkers reflecting the pathogenesis, clinical manifestations, and guide therapeutic approach in systemic sclerosis: a narrative review.反映系统性硬化症发病机制、临床表现和指导治疗方法的生物标志物:叙述性综述。
Clin Rheumatol. 2024 Oct;43(10):3055-3072. doi: 10.1007/s10067-024-07123-y. Epub 2024 Aug 29.
3
Biomarkers in Systemic Sclerosis: An Overview.系统性硬化症中的生物标志物:概述

本文引用的文献

1
Vascular Regulation of Developmental Neurogenesis.发育性神经发生的血管调节
Front Cell Dev Biol. 2022 Apr 29;10:890852. doi: 10.3389/fcell.2022.890852. eCollection 2022.
2
Raynaud's Phenomenon with Focus on Systemic Sclerosis.以系统性硬化症为重点的雷诺现象
J Clin Med. 2022 Apr 28;11(9):2490. doi: 10.3390/jcm11092490.
3
Nailfold capillaroscopy in systemic sclerosis - state of the art: The evolving knowledge about capillaroscopic abnormalities in systemic sclerosis.系统性硬化症中的甲襞毛细血管镜检查——最新进展:关于系统性硬化症毛细血管镜异常的不断发展的知识。
Curr Issues Mol Biol. 2023 Sep 25;45(10):7775-7802. doi: 10.3390/cimb45100490.
4
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.系统性硬化症发病机制、诊断及治疗中的生物标志物
J Inflamm Res. 2023 Oct 17;16:4633-4660. doi: 10.2147/JIR.S379815. eCollection 2023.
5
Advances in Systemic Sclerosis: From Pathogenetic Pathways toward Novel Therapeutic Targets.系统性硬化症的进展:从发病机制到新型治疗靶点
Life (Basel). 2023 Feb 13;13(2):513. doi: 10.3390/life13020513.
6
Current Trends in Vascular Biomarkers for Systemic Sclerosis: A Narrative Review.当前系统性硬化症的血管生物标志物研究趋势:一项叙述性综述。
Int J Mol Sci. 2023 Feb 17;24(4):4097. doi: 10.3390/ijms24044097.
J Scleroderma Relat Disord. 2019 Oct;4(3):200-211. doi: 10.1177/2397198319833486. Epub 2019 Apr 15.
4
Management of Endothelial Dysfunction in Systemic Sclerosis: Current and Developing Strategies.系统性硬化症中内皮功能障碍的管理:当前及发展中的策略
Front Med (Lausanne). 2021 Dec 22;8:788250. doi: 10.3389/fmed.2021.788250. eCollection 2021.
5
Pathophysiology of systemic sclerosis.系统性硬化症的病理生理学。
Presse Med. 2021 Apr;50(1):104087. doi: 10.1016/j.lpm.2021.104087. Epub 2021 Oct 28.
6
Current Concepts on the Pathogenesis of Systemic Sclerosis.系统性硬化症发病机制的现代概念。
Clin Rev Allergy Immunol. 2023 Jun;64(3):262-283. doi: 10.1007/s12016-021-08889-8. Epub 2021 Sep 6.
7
A Practical Approach to the Management of Digital Ulcers in Patients With Systemic Sclerosis: A Narrative Review.系统性硬化症患者数字化溃疡的管理实用方法:叙述性综述。
JAMA Dermatol. 2021 Jul 1;157(7):851-858. doi: 10.1001/jamadermatol.2021.1463.
8
New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine.治疗系统性硬化症的新有前途药物:发病机制的考虑、增强的分类和个体化医学。
Expert Opin Investig Drugs. 2021 Jun;30(6):635-652. doi: 10.1080/13543784.2021.1923693. Epub 2021 May 13.
9
Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer.可溶性神经纤毛蛋白-1 是早期乳腺癌不良预后的独立标志物。
J Cancer Res Clin Oncol. 2021 Aug;147(8):2233-2238. doi: 10.1007/s00432-021-03635-1. Epub 2021 Apr 21.
10
Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis.Semaphorins:从血管生成到类风湿关节炎的炎症。
Arthritis Rheumatol. 2021 Sep;73(9):1579-1588. doi: 10.1002/art.41701. Epub 2021 Aug 6.